Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Safety, Efficacy, and Pharmacokinetics of Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Neurological Autoimmune Diseases

NCT07337785 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07337785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07337785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Safety, Efficacy, and Pharmacokinetics of Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Neurological Autoimmune Diseases
Lead sponsor
Tongji Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
December 12, 2025
Completion date
November 1, 2028
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune encephalitis (ae), chronic inflammatory demyelinating polyneuropathy (cidp), myasthenia gravis (mg), relapsing or refractory multiple sclerosis (ms)